| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |